Tag Archives: Patient Protection and Affordable Care Act

The Yin and Yang of the Court Decision on HCR

by Tom Norton If you’re like me, you probably bounded out of bed on Thursday morning, took in all the news you could find about the Supreme Court and healthcare reform…and then you waited.  You waited patiently for the biggest legal call in American healthcare history.  And then, there it was. What did we learn?  […]
Posted in FDA, healthcare, leadership, Legal, Market Access, Regulatory, Strategy | Also tagged , , , | 1 Comment

Patient Assistance Programs: Are They Still Relevant?

One of the key reputational assets of Big Pharma is the patient assistance program [PAP], which provides patented innovative medicines to needy patients for free or at a nominal charge – it’s the industry’s own branded version of the social safety net. But a shifting landscape of government fiscal pressures, economic decline and the erratic […]
Posted in healthcare, Regulatory | Also tagged , , , , | Leave a comment

HCR and the Supreme Court: Three Important Days in March

The Supreme Court will open up deliberations on the constitutionality of three important parts of healthcare reform (HCR) this month. by Tom Norton After nearly two years of legal wrangling, on November 14, 2011 the Supreme Court (SCOTUS) determined that as a result of contradictory US Appellate Courts findings on the Patient Protection and Affordable […]
Posted in healthcare, Legal, Strategy | Also tagged , , , | Leave a comment

Compliance: Europe Feels the Sunshine

As the perceived urgency for transparency and compliance in global pharma grows ever stronger, the ‘Sunshine provisions’ of the US’s Patient Protection and Affordable Care Act (ACA) seem increasingly aptly named. The spotlight that has been exposing and illuminating – and sometimes burning – issues around the financial interests of physicians and academic medical centers […]
Posted in compliance, Europe | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta